DEHP and its active metabolites: leaching from different tubing types,impact on proinflammatory cytokines and adhesion molecule expression. Is there a subsumable context?
Restricted accessResearch articleFirst published online January, 2012
DEHP and its active metabolites: leaching from different tubing types,impact on proinflammatory cytokines and adhesion molecule expression. Is there a subsumable context?
Introduction: Di(2-ethylhexyl)phthalate (DEHP) is suspected to be toxic for several reasons. During contact with a lipophilic medium, DEHP leaks from polyvinylchloride (PVC), but its influence on inflammatory reactions remains unknown. We examined specific DEHP leaching out of different tubing types, the possibly modulated liberation of proinflammatory cytokines and the induction of adhesion molecule expression in primary endothelial cells.
Materials and Methods: Blood samples were circulated in traditional PVC, nodioctyl phthalate (DOP) PVC and heparin-coated PVC tubing within a Chandler loop model. The blood was tested for the concentration of DEHP and its active metabolites as well as the liberation of the proinflammatory cytokines TNFα and IL1ß. Furthermore, we exposed human endothelial cells to circulated blood and analysed them for the expression of the adhesion molecules ICAM-1, VCAM-1 and E-selectin.
Results: In contrast to the other tubing, PVC tubing showed significantly elevated DEHP levels, but no alteration was observed concerning a potential up-regulation of the cytokines or activation of the endothelial adhesion molecule receptors.
Conclusions: Our data conclude that there is no correlation between DEHP leaching and the inflammatory response after ECC support, but this study showed that even DEHP-free material is leaching DEHP and its toxic metabolites.
HillSSShawBRWuAH. The clinical effects of plasticizers, antioxidants, and other contaminants in medical polyvinylchloride tubing during respiratory and non- respiratory exposure. Clin Chim Acta2001; 304(1-2): 1–8.
7.
WendelHPHauserNBriquetFZiemerG. Hemo-compatibility of medical connectors with biopassive or bioactive surface coatings. J Biomater Appl2002; 17(1): 5–17.
8.
WendelHPZiemerG. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg1999; 16(3): 342–350.
9.
HildenbrandSLLehmannHDWodarzRZiemerGWendelHP. PVC-plasticizer DEHP in medical products: do thin coatings really reduce DEHP leaching into blood?Perfusion2005; 20(6): 351–357.
10.
HorneDCTorranceIModineTGourlayT. The effect of priming solutions and storage time on plasticizer migration in different PVC tubing types–implications for wet storage of ECMO systems. J Extra Corpor Technol2009; 41(4): 199–205.
11.
HanJBeetonALongP. Plasticizer di(2-ethylhexyl)phthalate (DEHP) release in wet-primed extracorporeal membrane oxygenation (ECMO) circuits. Int J Pharm2005; 294(1-2): 157–159.
12.
FukutomiMKobayashiSNiwayaKHamadaYKitamuraS. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs1996; 20(7): 767–776.
13.
KagisakiKMasaiTKadobaK. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artif Organs1997; 21(7): 836–840.
14.
KornRLFisherCALivingstonER. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. J Thorac Cardiovasc Surg1996; 111(5): 1073–1084.
15.
WendelHPHellerWGallimoreMJHoffmeisterHE. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model. Blood Coagul Fibrinolysis1994; 5(5): 673–678.
16.
HaishimaYMatsudaRHayashiYHasegawaCYagamiTTsuchiyaT. Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood circuits during hemodialysis and pump-oxygenation therapy. Int J Pharm2004; 274(1-2): 119–129.
17.
HarlanJMWinnRK. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med2002; 30(5 Suppl): S214–S219.
18.
HopeSAMeredithIT. Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J2003; 33(8): 380–386.
19.
HopeSAMeredithIT. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J2003; 33(9-10): 450–462.
20.
TedderTFSteeberDAChenAEngelP. The selectins: vascular adhesion molecules. FASEB J1995; 9(10): 866–873.
21.
AsimakopoulosGTaylorKM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg1998; 66(6): 2135–2144.
22.
PasnikJBajZMollJA. Effects of cardiopulmonary bypass on the expression of adhesive molecules in children undergoing cardiac surgery due to congenital heart disorders. Kardiol Pol2004; 60(2): 123–131.
23.
WildhirtSMSchulzeCSchulzC. Reduction of systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting. Shock2001; 16Suppl 1: 55–59.
24.
PaulAAvci-AdaliMNeumannB. Aptamers influence the hemostatic system by activating the intrinsic coagulation pathway in an in vitro Chandler-Loop model. Clin Appl Thromb Hemost2010; 16(2): 161–169.
25.
NolteARaabeCWalkerTSimonPZiemerGWendelHP. Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells. Oligonucleotides2009; 19(2): 141–150.
26.
RozenSSkaletskyH. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol2000; 132: 365–386.
27.
SimonPFeldkaemperMBitzerMOhngemachSSchaeffelF. Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens. Mol Vis2004; 10: 588–597.
28.
WalkerTWendelHPTetzloffL. Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J Cell Mol Med2007; 11(1): 139–147.
29.
GangolliSD. Testicular effects of phthalate esters. Environ Health Perspect1982; 45: 77–84.
30.
LycheJLGutlebACBergmanA. Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev2009; 12(4): 225–249.
31.
KarleVAShortBLMartinGR. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. Crit Care Med1997; 25(4): 696–703.
32.
KambiaKDineTAzarRGressierBLuyckxMBrunetC. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing. Int J Pharm2001; 229(1-2): 139–146.
33.
LoffSKabsFSuboticUSchaibleTReineckeFLangbeinM. Kinetics of diethylhexyl-phthalate extraction from polyvinylchloride-infusion lines. JPEN J Parenter Enteral Nutr2002; 26(5): 305–309.
34.
GourlayT. Biomaterial development for cardiopulmonary bypass. Perfusion2001; 16(5): 381–390.
35.
WeberNWendelHPZiemerG. Gene monitoring of surface-activated monocytes in circulating whole blood using duplex RT-PCR. J Biomed Mater Res2001; 56(1): 1–8.
36.
YamadaHKudohIHiroseYToyoshimaMAbeHKurahashiK. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass. Acta Anaesthesiol Scand1996; 40(3): 311–317.
37.
LappegardKTFungMBergsethGRiesenfeldJMollnesTE. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. Ann Thorac Surg2004; 78(1): 38–44.
38.
AshrafSButlerJTianY. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann Thorac Surg1998; 65(2): 480–484.
39.
SteinbergBMGrossiEASchwartzDS. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg1995; 60(3): 525–529.
40.
AsimakopoulosGLidingtonEAMasonJHaskardDOTaylorKMLandisRC. Effect of aprotinin on endothelial cell activation. J Thorac Cardiovasc Surg2001; 122(1): 123–128.
